On June 1, 2016, the Company entered into a Stock Purchase Agreement with Anthony R Smith to purchase 80% of the ownership of Smith Scientific Industries, Inc. d/b/a Kenevir Research, for 300,000 shares of Series "C" preferred stock, $236,000 promissory note, with a down payment of $100,000. $25,000 was paid in cash at closing with the remaining balance to be paid within six months.
1) The Company's wholly owned subsidiary EVIO Inc. has executed an executive employment agreement with Anthony R. Smith PhD. to become the Chief Science Officer overseeing all of EVIO Labs facilities. 2) Anthony R. Smith PhD has been appointed to the Board of Directors of Signal Bay, Inc. 3) William Waldrop and Lori Glauser have been appointed to the Board of Directors and Managers of Smith Scientific Industries, Inc.
Market Data 
Markets 
AI
